HANGZHOU, China, Dec. 20, 2023 /PRNewswire/ -- Recently, a CAR-macrophage therapy product (CAR-M) SY001 from CellOrigin Biotechnology (Hangzhou) Co., Ltd. was dosed to the first patient in a ...

HANGZHOU, China, Oct. 15, 2021 /PRNewswire/ -- On Oct. 11 th, 2021, CellOrigin Inc. released data about its second generation of iPSC-CAR-Macrophage which has a genetically integrated secondary ...

In their published article, Klichinsky used CAR targeting HER2 to modify macrophages, with a mouse model to evaluate the tumor-killing effect of CAR-macrophage (CAR-M) cells. In the SKOV3 human ...

To overcome this obstacle, some researchers have started adding CARs to immune cells other than T cells. On March 18, Carisma Therapeutics, a company founded by researchers at the University of ...

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Chimeric Antigen Receptor Macrophage (CAR-M) Immunotherapy - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.

HANGZHOU, China, Dec. 20, 2023 /PRNewswire/ -- Recently, a CAR-macrophage therapy product (CAR-M) SY001 from CellOrigin Biotechnology (Hangzhou) Co., Ltd. was dosed to the first patient in a ...